DYNORMIN TABLET 100MG

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

ATENOLOL

Boleh didapati daripada:

DYNAPHARM (M) SDN BHD

INN (Nama Antarabangsa):

ATENOLOL

Unit dalam pakej:

100 Tablets; 500 Tablets

Dikeluarkan oleh:

DYNAPHARM (M) SDN BHD

Risalah maklumat

DYNORMIN TABLET
_Consumer Medication Information Leaflet (RiMUP) _
Atenolol (50mg, 100mg)
1
What is in this leaflet
1.
What Dynormin is used for
2.
How Dynormin works
3.
Before you take Dynormin
4.
How to take Dynormin
5.
While you are using Dynormin
6.
Side effects
7.
Storage and disposal of Dynormin
8.
Product description
9.
Manufacturer and product registration
holder
10.
Date of revision
1.
WHAT DYNORMIN IS USED FOR
Dynormin contains the active ingredient
atenolol. It belongs to a group of medicines
called beta-blockers.
It is used to:
-
control high blood pressure.
-
relieve chest pain (angina pectoris).
-
control irregular heart beat.
-
protect the heart in the early treatment
after a heart attack.
2.
HOW DYNORMIN WORKS
Dynormin works by slowing down the
heart and reducing its workload.
3.
BEFORE YOU TAKE DYNORMIN
_When you must not use it _
Do not take Dynormin Tablet and tell your
doctor if you:
-
are allergic (hypersensitive) to atenolol or
any of the other ingredients in Dynormin
Tablet – refer section 8.
-
have second or third degree heart block.
-
have shock caused by heart problems.
-
have heart failure which is not under
control.
-
suffer with heart conduction or rhythm
problems
-
have a slow heart rate
-
have low blood pressure.
-
suffer from an increased acidity of the
blood (metabolic acidosis)
-
have or have had breathing problems
such as asthma, difficulty breathing due
to narrowing of the airways or reversible
obstructive airways disease. Do not take
this medicine if you have a history of
wheezing or asthma. Consult your doctor
or pharmacist first.
_Before you start to use it _
Take special care with Dynormin Tablet
and tell your doctor if you:
-
have a history of allergic reactions
-
have heart problems such as heart failure,
untreated congestive heart failure,
ischaemic heart disease, poor heart
function (poor cardiac reserve) or first
degree heart block.
-
suffer from blood circulation problems
(which may cause your fingers and toes
to tingle or turn pale or blue) or cramping
pain causing

Ciri produk

DYNORMIN
DESCRIPTION
CONTENT
DYNORMIN TABLET 50MG
MAL19971838AZ
MYN1501AA2084
TABLET
Colour
:
White
Shape
:
Round, Biconvex and Scored
Coating
:
Film-coated
Each Tablet Contains:
Atenolol ........................ 50 mg
DYNORMIN TABLET 100MG
MAL19913259AZ
TABLET
Colour
:
Orange
Shape
:
Round, Biconvex and Scored
Marking :
“D”
Coating
:
Film-coated
Each Tablet Contains:
Atenolol ...................... 100 mg
PHARMACODYNAMICS:
Atenolol is a β-adrenoceptor blocking agent which is cardioselective
(i.e. acts preferentially on β-adrenergic receptors in the
heart). It is without intrinsic sympathomimetic and membrane
stabilising activities. It crosses the blood brain barrier only to a
negligible extent. Atenolol is effective for at least 24 hours after a
single oral dose.
PHARMACOKINETICS:
Atenolol appears to be incompletely absorbed from the gastrointestinal
tract and is not significantly metabolised. It is excreted
in the urine and its biological half-life is longer than would be
anticipated from its plasma half-life of about 6 to 7 hours.
Atenolol diffuses across the placenta and is excreted in the breast
milk. Only small amounts are reported to cross the blood-
brain-barrier, and it is only about 5% bound to plasma proteins.
INDICATION:
Control of hypertension. Management of angina pectoris and cardiac
dysrhythmias. Prophylaxis of myocardial infraction.
RECOMMENDED DOSE:
Hypertension: Most patients reported to 50 - 100 mg daily given orally
as a single dose. The effect will be fully established after
one to two week.
Angina: Most patients with angina pectoris will respond to 100 mg
daily given orally as a single or divided dose. It is unlikely that
additional benefit will be gained by increasing the dose.
Dysrhythmias: Having controlled the dysrhythmias with intravenous
administration of Atenolol, a suitable oral maintenance
dosage is 50 - 100 mg daily, given as a single dose.
Myocardial Infarction: Treatment should be given within 12 hours of
the onset of chest pain: 5 to 10 mg should be given by I.V.
injectio